维普中文期刊产品整合服务
17篇 您的检索式:作者名="Rensch F"
    题名 作者 年代 出处 被引量
1Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endethelial hyaluronan receptor (LYVE- 1 )显示文摘Trojan L Michel M S Rensch F 2004Urol2004,172,1:1
2Lymph and blood ves-sel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan rocep-tor (LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
3Lymph and blood vessel architecture in benign and malignant prostatic tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
4Lymph and blood vessel architecture in benign and malignant prostan'c tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor(LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
5Progression of tractional retinal detachment following intravitreal bevacizumab显示文摘Jonas JB Schmidbauer M Rensch F 0,,:1
6Lymph and blood vessel architecture in benign and malignant prostatic tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor(LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
7Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion显示文摘RENSCH F JONAS J B SPANDAU U H 2009Ophthalmologica2009,223,2:1
8Lymph and blood vessel architecture in benign and malignant prostatic tissue: Lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor(LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
9Lymph and blood vessel architecture in benign and malignant prostatic tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
10The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer显示文摘Trojan L Rensch F Voss M 2006BJU International2006,98,4:1
11Direct microperimetry of alpha zone and beta zone parapapillary atrophy显示文摘Rensch F Jonas JB 2008Br J Ophthalmol2008,92,12:1
12Progression of tractional retinal detachment following intravitreal bevacizumab 显示文摘Jonas JB Schmidbauer M Rensch F 2009Acta Ophthalmol2009,87,5:1
13Lymph and blood vessel architecture in benign and malignant prostatic tissue:lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)显示文摘Trojan L Michel MS Rensch F 2004J Urol2004,172,1:1
14Direct microperimetry of alpha zone and beta zone parapapillary atrophy显示文摘Rensch F Jonas JB 2008Br J Ophthalmol2008,92,:1
15The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lyrnphogenic metastasis in prostate cancer 显示文摘Trojan L Rensch F Voss M 2006BJU Int2006,98,4:1
16Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion显示文摘Rensch F Jonas JB Spandau UN 2009Ophthalmologica2009,233,2:1
17Lymph and blood vessel architecture in benign and malignant prostatic tissue : lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endethelial hyaluronan receptor(LYVE-1) 显示文摘Trojan L Michel M S Rensch F 2004J Urol2004,172,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费